Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Salvati

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Communications Biology|March 2, 2023
PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitmentC Maresca, A Dello Stritto, C D'Angelo, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleusMark E Salvati, Aaron Balog, Donna D Wei, et al.
Journal of Pharmaceutical Sciences|January 11, 2018
Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical SpeciesXue-Qing Chen, Theresa Ziemba, Christine Huang, et al.
Oncogene|August 31, 2010
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapyE Salvati, M Scarsella, M Porru, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosteroneJ S Sack, K F Kish, C Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2016
Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitorsJi Jiang, Heather Finlay, James A Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonistsMark E Salvati, Aaron Balog, Weifang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
Pyrrolopyridazine MEK inhibitorsZhong Chen, Soong-Hoon Kim, Stephanie A Barbosa, et al.
The Prostate|September 30, 2010
Drug safety is a barrier to the discovery and development of new androgen receptor antagonistsWilliam R Foster, Bruce D Car, Hong Shi, et al.
The Prostate|June 1, 2005
Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3)Thomas E Spires, Brian E Fink, Ellen K Kick, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Communications Biology|March 2, 2023
PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitmentC Maresca, A Dello Stritto, C D'Angelo, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleusMark E Salvati, Aaron Balog, Donna D Wei, et al.
Journal of Pharmaceutical Sciences|January 11, 2018
Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical SpeciesXue-Qing Chen, Theresa Ziemba, Christine Huang, et al.
Oncogene|August 31, 2010
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapyE Salvati, M Scarsella, M Porru, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosteroneJ S Sack, K F Kish, C Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2016
Discovery of hydroxyl 1,2-diphenylethanamine analogs as potent cholesterol ester transfer protein inhibitorsJi Jiang, Heather Finlay, James A Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonistsMark E Salvati, Aaron Balog, Weifang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
Pyrrolopyridazine MEK inhibitorsZhong Chen, Soong-Hoon Kim, Stephanie A Barbosa, et al.
The Prostate|September 30, 2010
Drug safety is a barrier to the discovery and development of new androgen receptor antagonistsWilliam R Foster, Bruce D Car, Hong Shi, et al.
The Prostate|June 1, 2005
Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3)Thomas E Spires, Brian E Fink, Ellen K Kick, et al.
Pageof 22